Available Structures
21 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| S65DParkin and pUB complex |
Heteromer P0CG47; | 98.73 | 1×PEG; 1×CL; 8×ZN; | |||
| WT-Parkin and pUB complex |
Heteromer P0CG47; | 100.0 | 8×ZN; 1×CL; 2×TMO; | |||
| Structure of phospho-Parkin bound to phospho-ubiquitin |
Heteromer P0CG47; | 99.68 | 6×ZN; 3×GOL; 1×MPD; 1×SO4; | |||
| Trans complex of phospho parkin |
Heteromer P62987; | 99.57 | 6×ZN; 1×GOL; 1×PEG; | |||
| Ternary trans-complex of phospho-parkin with cis ACT and pUb |
Heteromer P62987; | 99.58 | 6×ZN; 2×GOL; 1×MPD; 1×3CN; | |||
| pUbl depleted Parkin complex with pUbiquitin |
Heteromer P62987; | 99.34 | 8×ZN; 7×SO4; | |||
| ParkinK211N in complex with phospho NEDD8 |
Heteromer Q15843; | 99.68 | 8×ZN; 3×PEG; | |||
| Parkin in complex with phospho NEDD8 |
Heteromer Q15843; | 100.0 | 8×ZN; 3×EDO; | |||
| pUbl depleted phospho-Parkin(K211N,R163D) in complex with pUb |
Heteromer P62987; | 99.03 | 8×ZN; 2×PEG; | |||
| UbcH7-Ub Complex with R0RBR Parkin and phosphoubiquitin |
Heteromer P0CG47; P0CG48; P68036; | 99.69 | 8×ZN; | |||
| Structure of the autoinhibited Parkin catalytic domain | homo-6-mer | 100.0 | 48×ZN; 18×SO4; 6×GOL; | |||
| Parkin (UblR0RBR) | monomer | 100 | 8×ZN; 1×SO4; 2×GOL; 1×CL; | |||
| Parkin (S65DUblR0RBR) | monomer | 98.8 | 8×ZN; 2×GOL; 2×SO4; 1×CL; | |||
| ParkinS65N | monomer | 98.77 | 8×ZN; 1×SO4; 2×GOL; 1×CL; | |||
| Structure of Parkin-S223P E3 ligase | monomer | 99.67 | 8×ZN; 1×BA; | |||
| Structure of Parkin E3 ligase | monomer | 100.0 | 8×ZN; | |||
| Untethered R0RBR | monomer | 99.67 | 8×ZN; 2×GOL; 1×BA; | |||
| Structure of human Parkin G319A | monomer | 99.67 | 8×ZN; 6×SO4; 3×GOL; | |||
| IBR domain of Human Parkin | monomer | 100 | 2×ZN; | |||
| Solution structure of Serine 65 phosphorylated UBL domain from parkin | monomer | 100 | ||||
| Solution structure of ubiquitin-like domain of human parkin | monomer | 100 | ||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5c1z.1.A | monomer | 0.73 | 8×ZN; | 99.01 | ||
| 5n2w.1.A | monomer | 0.69 | 8×ZN; 1×TMO; | 91.36 | ||
18 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 5c1z.1.A | monomer | 0.70 | 7×ZN; | 98.67 | ||
| Isoform 2 | 5n2w.1.A | monomer | 0.65 | 7×ZN; | 90.72 | ||
| Isoform 3 | 6glc.1.A | monomer | 0.74 | 3×ZN; | 99.53 | ||
| Isoform 4 | 8wzo.1.A | monomer | 0.78 | 6×ZN; 1×EDO; | 100.00 | ||
| Isoform 4 | 4bm9.1.A | monomer | 0.76 | 6×ZN; | 100.00 | ||
| Isoform 5 | 6glc.1.A | monomer | 0.75 | 5×ZN; | 98.90 | ||
| Isoform 5 | 4k95.1.A | monomer | 0.68 | 5×ZN; | 84.34 | ||
| Isoform 5 | 5c1z.1.A | monomer | 0.63 | 4×ZN; | 88.40 | ||
| Isoform 6 | 6glc.1.A | monomer | 0.81 | 4×ZN; | 91.81 | ||
| Isoform 6 | 5n2w.1.A | monomer | 0.76 | 6×ZN; | 94.94 | ||
| Isoform 6 | 4k7d.2.A | monomer | 0.72 | 6×ZN; | 89.35 | ||
| Isoform 6 | 7r70.2.A | monomer | 0.59 | 20.00 | |||
| Isoform 7 | 4k95.1.A | monomer | 0.62 | 6×ZN; | 83.72 | ||
| Isoform 7 | 6glc.1.A | monomer | 0.60 | 3×ZN; | 85.63 | ||
| Isoform 7 | 5n2w.1.A | monomer | 0.57 | 5×ZN; | 88.38 | ||
| Isoform 8 | 4k95.1.A | monomer | 0.65 | 7×ZN; | 82.41 | ||
| Isoform 8 | 6glc.1.A | monomer | 0.62 | 4×ZN; | 87.53 | ||
| Isoform 8 | 5n2w.1.A | monomer | 0.61 | 6×ZN; 1×TMO; | 90.42 | ||